Rennova Health Valuation

RNVADelisted Stock  USD 0.0001  0.00  0.00%   
Rennova Health seems to be overvalued based on Macroaxis valuation methodology. Our model determines the value of Rennova Health from analyzing the company fundamentals such as Return On Asset of -0.0862, current valuation of 18.13 M, and Shares Owned By Institutions of 9.00 % as well as examining its technical indicators and probability of bankruptcy. In general, most investors support taking in undervalued entities and trading overvalued entities since, at some point, asset prices and their ongoing real values will merge together.
Overvalued
Today
0.0001
Please note that Rennova Health's price fluctuation is very steady at this time. Calculation of the real value of Rennova Health is based on 3 months time horizon. Increasing Rennova Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Rennova Health is useful when determining the fair value of the Rennova pink sheet, which is usually determined by what a typical buyer is willing to pay for full or partial control of Rennova Health. Since Rennova Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Rennova Pink Sheet. However, Rennova Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  1.0E-4 Real  6.4E-5 Hype  1.0E-4
The real value of Rennova Pink Sheet, also known as its intrinsic value, is the underlying worth of Rennova Health Company, which is reflected in its stock price. It is based on Rennova Health's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Rennova Health's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Rennova Health's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
0.000064
Real Value
0.00
Upside
Estimating the potential upside or downside of Rennova Health helps investors to forecast how Rennova pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Rennova Health more accurately as focusing exclusively on Rennova Health's fundamentals will not take into account other important factors:
Hype
Prediction
LowEstimatedHigh
0.000.00010.00
Details

Rennova Health Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Rennova Health's current stock value. Our valuation model uses many indicators to compare Rennova Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Rennova Health competition to find correlations between indicators driving Rennova Health's intrinsic value. More Info.
Rennova Health is currently regarded as top stock in beta category among related companies. It is rated below average in price to earning category among related companies . . Comparative valuation analysis is a catch-all model that can be used if you cannot value Rennova Health by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Rennova Health's Pink Sheet . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Rennova Health's earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Rennova Health's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Rennova Health and how it compares across the competition.

About Rennova Health Valuation

The pink sheet valuation mechanism determines the current worth of Rennova Health on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Rennova Health. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Rennova Health based exclusively on its fundamental and basic technical indicators. By analyzing Rennova Health's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Rennova Health's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Rennova Health. We calculate exposure to Rennova Health's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Rennova Health's related companies.
Rennova Health, Inc., together with its subsidiaries, provides health care services in the United States. The company was founded in 2005 and is based in West Palm Beach, Florida. Rennova Health operates under Diagnostics Research classification in the United States and is traded on OTC Exchange. It employs 57 people.

8 Steps to conduct Rennova Health's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Rennova Health's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Rennova Health's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Rennova Health's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Rennova Health's revenue streams: Identify Rennova Health's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Rennova Health's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Rennova Health's growth potential: Evaluate Rennova Health's management, business model, and growth potential.
  • Determine Rennova Health's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Rennova Health's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Rennova Health Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Rennova Health does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding2987.00
Retained Earnings-1.4 B
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.
You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Consideration for investing in Rennova Pink Sheet

If you are still planning to invest in Rennova Health check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Rennova Health's history and understand the potential risks before investing.
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas